Development of a Pilot Program to Reduce Nitazoxanide Utilization at a Major Cancer Center in Patients with Discordant Norovirus Testing

Key Points

• Reduced nitazoxanide use demonstrates effective intervention in clinicians' decision-making processes.
• Utilization of nitazoxanide decreased by 30% over six months in patients receiving discordant norovirus testing.
• Pilot program implementation involved targeted educational sessions and updated guidelines for clinicians.
• Findings support the potential for similar programs in other cancer centers to improve treatment protocols.